Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Exploratory Study of Zanidatamab in HER2-positive Advanced Tumor After at Least One Line of Standard Therapy

NCT07631871 is registered in ClinicalTrials.gov with Haihua Yuan as lead sponsor.

NCT NCT07631871
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07631871 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Exploratory Study of Zanidatamab in HER2-positive Advanced Tumor After at Least One Line of Standard Therapy
Lead sponsor
Haihua Yuan
Phase
Phase 2
Overall status
Not yet recruiting
Start date
June 15, 2026
Completion date
December 31, 2029
Enrollment
10 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cervical neoplasms, colorectal neoplasms, endometrial neoplasm, head and neck neoplasms, her2 positive solid tumor, neoplasms, ovarian neoplasms, pancreatic neoplasms, solid tumors, urothelial carcinoma (uc)